论文部分内容阅读
作者观察150例、20～50岁慢性化脓性中鼓室炎患者用超免疫血浆(hyperimmune plasma)局部治疗的效果。自患者中耳内分离出各类细菌并制成超免疫血浆使用,观察期在2年以上,82%患者远期疗效持久。治疗前中耳分泌物细菌培养结果:96.5%系单一菌种生长,最多者为金葡菌,占63%;绿脓杆菌20.1%;变形杆菌及大肠杆菌16.9%;3.5%为不止一种细菌生长。治疗后培养转阴率:金葡菌感染者为87%,绿脓杆菌者63%,变形杆菌和大肠杆菌者84%。为检查患者的免疫功能状况,于治疗前和治
The authors observed the effect of topical treatment with hyperimmune plasma in 150 patients 20 to 50 years of chronic suppurative mechitis. Isolated from the middle ear of patients with various types of bacteria and made of hyperimmune plasma use, the observation period of 2 years or more, 82% of patients with long-term long-term efficacy. Bacterial culture results of middle ear secretions before treatment: 96.5% of single bacteria growth, most of Staphylococcus aureus, accounting for 63%; Pseudomonas aeruginosa 20.1%; Proteus and Escherichia coli 16.9%; 3.5% for more than one bacteria Grow. After treatment, the negative conversion rate: Staphylococcus aureus was 87%, Pseudomonas aeruginosa 63%, Proteus and Escherichia coli 84%. To check the patient’s immune function, before treatment and treatment